代谢相关性脂肪性肝病的相关影响因素
Related Factors of Metabolic Associated Fatty Liver Disease
摘要: 随着医疗技术的不断进步以及人民生活方式的改变，全球慢性肝病的病因谱已经发生了巨大变化。脂肪肝已然成为全球最常见的慢性肝病，其中非酒精性脂肪性肝病(nonalcoholic fatty liver disease, NAFLD)占据比例更大。目前非酒精性脂肪性肝病已被多位专家更名为代谢相关性脂肪性肝病(metabolic associated fatty liver disease, MAFLD)。MAFLD已成为全世界最主要的非传染性肝病，严重威胁着人类的生命健康。本综述旨在介绍代谢相关性脂肪性肝病的几大影响因素，从而为更好地预防和控制疾病起到指导作用。
Abstract: With the continuous progress of medical technology and the change of people’s lifestyle, the etiological spectrum of chronic liver disease in the world has changed greatly. Fatty liver has become the most common chronic liver disease in the world, among which nonalcoholic fatty liver disease (NAFLD) occupies a larger proportion. At present, nonalcoholic fatty liver disease has been renamed as metabolic associated fatty liver disease (MAFLD) by many experts. MAFLD has become the most important non-infectious liver disease in the world, seriously threatening human life and health. This review aims to introduce several influential factors of metabolic associated fatty liver disease, so as to provide guidance for better prevention and control of the disease.
文章引用：黄饺饺, 易默, 史丽萍. 代谢相关性脂肪性肝病的相关影响因素[J]. 临床医学进展, 2022, 12(1): 331-336. https://doi.org/10.12677/ACM.2022.121050

参考文献

[1] Younossi, Z.M., Golabi, P., de Avila, L., Paik, J.M., Srishord, M., Fukui, N., et al. (2019) The Global Epidemiology of NAFLD and NASH in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Journal of Hepatology, 71, 793-801. [Google Scholar] [CrossRef] [PubMed]
[2] Tu, T. and Douglas, M.W. (2020) Hepatitis B Virus Infection: from Diagnostics to Treatments. Viruses, 12, Article No. 1366. [Google Scholar] [CrossRef] [PubMed]
[3] Grąt, K., Grąt, M. and Rowiński, O. (2020) Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines, 8, Article No. 298. [Google Scholar] [CrossRef] [PubMed]
[4] Huang, T.D., Behary, J. and Zekry, A. (2020) Non-Alcoholic Fatty Liver Disease: A Review of Epidemiology, Risk Factors, Diagnosis and Management. Internal Medicine Journal, 50, 1038-1047. [Google Scholar] [CrossRef] [PubMed]
[5] Younossi, Z.M. (2019) Non-Alcoholic Fatty Liver Disease—A Global Public Health Perspective. Journal of Hepatology, 70, 531-544. [Google Scholar] [CrossRef] [PubMed]
[6] Fouad, Y., Waked, I., Bollipo, S., Gomaa, A., Ajlouni, Y. and Attia, D. (2020) What’s in a Name? Renaming ‘NAFLD’to ‘MAFLD’. Liver International, 40, 1254-1261. [Google Scholar] [CrossRef] [PubMed]
[7] Yilmaz, Y., Byrne, C.D. and Musso, G. (2021) A Single-Letter Change in an Acronym: Signals, Reasons, Promises, Challenges, and Steps Ahead for Moving from NAFLD to MAFLD. Expert Review of Gastroenterology & Hepatology, 15, 345-352. [Google Scholar] [CrossRef] [PubMed]
[8] 韩琳, 谢欢, 孙颖, 邹正升. 代谢相关脂肪性肝病的诊断与评估现状[J]. 肝脏, 2021, 26(2): 205-210.
[9] Eslam, M., Newsome, P.N., Sarin, S.K., Anstee, Q.M., Targher, G., Romero-Gomez, M., et al. (2020) A New Definition for Metabolic Dysfunction-Associated Fatty Liver Disease: An International Expert Consensus Statement. Journal of Hepatology, 73, 202-209. [Google Scholar] [CrossRef] [PubMed]
[10] Eslam, M., Sanyal, A.J. and George, J. (2020) MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology, 158, 1999-2014.e1. [Google Scholar] [CrossRef] [PubMed]
[11] Barigou, M., Favre, L., Fraga, M. and Artru, F. (2020) New Trends in Non-Alcoholic Fatty Liver Diseases (NAFLD). Revue Médicale Suisse, 16, 586-591.
[12] Shiha, G., Alswat, K., Al Khatry, M., Sharara, A.I. Örmeci, N., Waked, I., Benazzouz, M., et al. (2021) Nomenclature and Definition of Metabolic-Associated Fatty Liver Disease: A Consensus from the Middle East and North Africa. The Lancet Gastroenterology and Hepatology, 6, 57-64. [Google Scholar] [CrossRef] 
[13] 范建高. 代谢相关脂肪性肝病现已成为我国第一大慢性肝病[J]. 中华医学信息导报, 2021, 36(6): 6.
[14] Friedman, S.L., Neuschwander-Tetri, B.A., Rinella, M. and Sanyal, A.J. (2018) Mechanisms of NAFLD Development and Therapeutic Strategies. Nature Medicine, 24, 908-922. [Google Scholar] [CrossRef] [PubMed]
[15] Kuk, J.L., Saunders, T.J., Davidson, L.E. and Ross, R. (2009) Age-Related Changes in Total and Regional Fat Distribution. Ageing Research Reviews, 8, 339-48. [Google Scholar] [CrossRef] [PubMed]
[16] Lonardo, A., Nascimbeni, F., Ballestri, S., Fairweather, D., Win, S., Than, T.A., et al. (2019) Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. Hepatology, 70, 1457-1469. [Google Scholar] [CrossRef] [PubMed]
[17] Rich, N.E., Oji, S., Mufti, A.R., Browning, J.D., Parikh, N.D., Odewole, M., et al. (2018) Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 16, 198-210.e2. [Google Scholar] [CrossRef] [PubMed]
[18] Struben, V.M., Hespenheide, E.E. and Caldwell, S.H. (2000) Nonalcoholic Steatohepatitis and Cryptogenic Cirrhosis within Kindreds. The American Journal of Medicine, 108, 9-13. [Google Scholar] [CrossRef] [PubMed]
[19] Yu, C., Xu, C., Xu, L., Yu, J., Miao, M. and Li, Y. (2012) Serum Proteomic Analysis Revealed Diagnostic Value of Hemoglobin for Nonalcoholic Fatty Liver Disease. Journal of Hepatology, 56, 241-247.
[20] Lee, Y.J., Lee, H.R., Shim, J.Y., Moon, B.S., Lee, J.H. and Kim, J.K. (2010) Relationship between White Blood Cell Count and Nonalcoholic Fatty Liver Disease. Digestive and Liver Disease, 42, 888-894. [Google Scholar] [CrossRef] [PubMed]
[21] Frith, J., Jones, D. and Newton, J.L. (2009) Chronic Liver Disease in an Ageing Population. Age Ageing, 38, 11-18. [Google Scholar] [CrossRef] [PubMed]
[22] Papatheodoridi, A.M., Chrysavgis, L., Koutsilieris, M. and Chatzigeorgiou, A. (2020) The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis. Hepatology, 71, 363-374. [Google Scholar] [CrossRef] [PubMed]
[23] Anderson, E.L., Howe, L.D., Jones, H.E., Higgins, J.P.T., Lawlor, D.A. and Fraser, A. (2015) The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLoS ONE, 10, Article ID: e0140908. [Google Scholar] [CrossRef] [PubMed]
[24] Zhou, F., Zhou, J., Wang, W., Zhang, X.J., Ji, Y.X., Zhang, P., et al. (2019) Unexpected Rapid Increase in the Burden of NAFLD in China from 2008 to 2018: A Systematic Review and Meta-Analysis. Hepatology, 70, 1119-1133. [Google Scholar] [CrossRef] [PubMed]
[25] Shen, J., Wong, G.L., Chan, H.L., Chan, H.Y., Yeung, D.K., Chan, R.S., et al. (2014) PNPLA3 Gene Polymorphism Accounts for Fatty Liver in Community Subjects Without Metabolic Syndrome. Alimentary Pharmacology & Therapeutics, 39, 532-539. [Google Scholar] [CrossRef] [PubMed]
[26] Guthold, R., Stevens, G.A., Riley, L.M. and Bull, F.C. (2018) Worldwide Trends in Insufficient Physical Activity from 2001 to 2016: A Pooled Analysis of 358 Population-Based Surveys with 1.9 Million Participants. The Lancet Global Health, 6, E1077-E1086. [Google Scholar] [CrossRef] [PubMed]
[27] Bambha, K., Belt, P., Abraham, M., Wilson, L.A., Pabst, M., Ferrell, L., et al. (2012) Ethnicity and Nonalcoholic Fatty Liver Disease. Hepatology, 55, 769-780. [Google Scholar] [CrossRef] [PubMed]
[28] Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., et al. (2017) Gut Microbiome-Based Metagenomic Signature for Non-Invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metabolism, 25, 1054-1062.e5. [Google Scholar] [CrossRef] [PubMed]
[29] Caussy, C. and Loomba, R. (2018) Gut Microbiome, Microbial Metabolites and the Development of NAFLD. Nature Reviews Gastroenterology & Hepatology, 15, 719-720. [Google Scholar] [CrossRef] [PubMed]
[30] Arab, J.P., Karpen, S.J., Dawson, P.A., Arrese, M. and Trauner, M. (2017) Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives. Hepatology, 65, 350-362. [Google Scholar] [CrossRef] [PubMed]
[31] Romero-Gómez, M., Zelber-Sagi, S. and Trenell, M. (2017) Treatment of NAFLD with Diet, Physical Activity and Exercise. Journal of Hepatology, 67, 829-846. [Google Scholar] [CrossRef] [PubMed]
[32] Trovato, F.M., Catalano, D., Martines, G.F., Pace, P. and Trovat,o G.M. (2015) Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: The Need of Extended and Comprehensive Interventions. Clinical Nutrition, 34, 86-88. [Google Scholar] [CrossRef] [PubMed]
[33] Barata, L., Feitosa, M.F., Bielak, L.F., Halligan, B., Baldridge, A.S., Guo, X., et al. (2019) Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals without Diabetes. Hepatology Communications, 3, 894-907. [Google Scholar] [CrossRef] [PubMed]
[34] Yoneda, M., Yamamoto, T., Honda, Y., Imajo, K., Ogawa, Y., Kessoku, T., et al. (2021) Risk of Cardiovascular Disease in Patients with Fatty Liver Disease As Defined from the Metabolic Dysfunction Associated Fatty Liver Disease Or Nonalcoholic Fatty Liver Disease Point of View: A Retrospective Nationwide Claims Database Study in Japan. Journal of Gastroenterology, 56, 1022-1032. [Google Scholar] [CrossRef] [PubMed]
[35] Lin, S., Huang, J., Wang, M., Kumar, R., Liu, Y., Liu, S., et al. (2020) Comparison of MAFLD and NAFLD Diagnostic Criteria in Real World. Liver International, 40, 2082-2089. [Google Scholar] [CrossRef] [PubMed]
[36] Li, H., Guo, M., An, Z., Meng, J., Jiang, J., Song, J., et al. (2020) Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China. International Journal of Environmental Research and Public Health, 17, Article No. 1818. [Google Scholar] [CrossRef] [PubMed]
[37] Kwon, Y.M., Oh, S.W., Hwang, S.S., Lee, C., Kwon, H. and Chung, G.E. (2012) Association of Nonalcoholic Fatty Liver Disease with Components of Metabolic Syndrome According to Body Mass Index in Korean Adults. The American Journal of Gastroenterology, 107, 1852-1858. [Google Scholar] [CrossRef] [PubMed]
[38] Zhang, H.J., He, J., Pan, L.L., Ma, Z.M., Han, C.K., Chen, C.S., et al. (2016) Effects of Moderate and Vigorous Exercise On Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial. JAMA Internal Medicine, 176, 1074-1082. [Google Scholar] [CrossRef] [PubMed]
[39] 蔡联英, 王文娟, 梁运啸, 宋怀宇. 代谢相关脂肪性肝病与代谢综合征相关性的研究进展[J]. 中国临床新医学, 2021, 14(7): 730-734.
[40] Yilmaz, Y., Senates, E., Ayyildiz, T., Colak, Y., Tuncer, I., Ovunc, A.O.K., et al. (2012) Characterization of Nonalcoholic Fatty Liver Disease Unrelated to the Metabolic Syndrome. European Journal of Clinical Investigation, 42, 411-418. [Google Scholar] [CrossRef] [PubMed]
[41] Akyuz, U., Yesil, A. and Yilmaz, Y. (2015) Characterization of Lean Patients with Nonalcoholic Fatty Liver Disease: Potential Role of High Hemoglobin Levels. Scandinavian Journal of Gastroenterology, 50, 341-346. [Google Scholar] [CrossRef] [PubMed]
[42] Yilmaz, Y. (2012) NAFLD in the Absence of Metabolic Syndrome: Different Epidemiology, Pathogenetic Mechanisms, Risk Factors for Disease Progression? Seminars in Liver Disease, 32, 14-21. [Google Scholar] [CrossRef] [PubMed]
[43] Xu, L., Xu, C.F., Yu, C.H., Miao, M. and Li, Y.M. (2009) Haemoglobin and Non-Alcoholic Fatty Liver Disease: Further Evidence from a Population-Based Study. Gut, 58, 1706-1707. [Google Scholar] [CrossRef] [PubMed]
[44] Wang, S., Zhang, C., Zhang, G., Yuan, Z., Liu, Y., Ding, L., et al. (2016) Association between White Blood Cell Count and Non-Alcoholic Fatty Liver Disease in Urban Han Chinese: A Prospective Cohort Study. BMJ Open, 6, Article ID: E010342.
[45] Ryu, S., Chang, Y., Kim, S.G., Cho, J and Guallar, E. (2011) Serum Uric Acid Levels Predict Incident Nonalcoholic Fatty Liver Disease in Healthy Korean Men. Metabolism, 60, 860-866. [Google Scholar] [CrossRef] [PubMed]
[46] Liu, C.Q., He, C.M., Chen, N., Wang, D., Shi, X., Liu, Y., et al. (2016) Serum Uric Acid Is Independently and Linearly Associated with Risk of Nonalcoholic Fatty Liver Disease in Obese Chinese Adults. Scientific Reports, 6, Article No. 38605. [Google Scholar] [CrossRef] [PubMed]
[47] Wei, F., Li, J., Chen, C., Zhang, K., Cao, L., Wang, X., et al. (2020) Higher Serum Uric Acid Level Predicts Non-Alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study. Frontiers in Endocrinology, 11, Article No. 179. [Google Scholar] [CrossRef] [PubMed]

为你推荐